<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392635</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-55013</org_study_id>
    <nct_id>NCT04392635</nct_id>
  </id_info>
  <brief_title>Device to Assist With Abdominal Access During Laparoscopic Surgery</brief_title>
  <official_title>Pilot Study to Establish Safety and Ease of Use of a Trocar Placement Access Device (TPAD) for Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>James Lau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TauTona Group</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and ease of use of a trocar placement
      access device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for
      placing a primary trocar, during laparoscopic surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgeon satisfaction survey</measure>
    <time_frame>up to 1 minute on day of surgery</time_frame>
    <description>The surgeon will complete a LIKERT scale satisfaction survey related to the TPAD to assess its ease of use. Scale range 1-5 (higher scores correspond to higher satisfaction)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time required to obtain peritoneal access and place primary trocar during laparoscopic surgery</measure>
    <time_frame>Up to 10 minutes</time_frame>
    <description>Time from incision to successful placement of primary trocar will be measured and reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0</measure>
    <time_frame>Continuous from start of surgery through postoperative day 7</time_frame>
    <description>Adverse events related to the surgery itself, or to the incision and skin around the incision where the TPAD is placed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">9</enrollment>
  <condition>Laparoscopic Surgery</condition>
  <arm_group>
    <arm_group_label>Trocar Placement Assist Device (TPAD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive investigational TPAD device during laparoscopic surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trocar Placement Assist Device (TPAD)</intervention_name>
    <description>The TPAD is an experimental device used to assist with placement of Veress needle and trocar during laparoscopic surgery.</description>
    <arm_group_label>Trocar Placement Assist Device (TPAD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;/= 18

          -  Scheduled for laparoscopic surgery

          -  Able to understand and willing to sign a written informed consent form

        Exclusion Criteria:

          -  Age &lt; 18

          -  Any situation where blind, peri-umbilical passage of a Veress needle is
             contraindicated.

          -  Any situation where patients have suspected or confirmed intra-abdominal adhesions
             involving the peri-umbilical abdominal wall.

          -  Any situation where patients have a suspected or confirmed umbilical hernia or
             peri-umbilical ventral hernia.

          -  Any situation where there is not intact, uncompromised skin of the peri-umbilical
             region where the device is to be placed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Lau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Study Team</last_name>
      <phone>650-736-2776</phone>
      <email>tcarlomagno@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Janos Barrera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>James Lau</investigator_full_name>
    <investigator_title>Professory of Surgery</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

